Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Calvert

Showing results (211-220 of 222) with videos related to

Pageof 23
Sort By:
BMJ (Clinical Research Ed.)|October 20, 2023
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidanceChristina Yap, Jan Rekowski, Moreno Ursino, et al.
Trials|August 31, 2017
A mixed-methods feasibility and external pilot study to inform a large pragmatic randomised controlled trial of the effects of surgical wound dressing strategies on surgical site infections (Bluebelle Phase B): study protocol for a randomised controlled trial, Barnaby C Reeves, Lazaros Andronis, et al.
The Lancet. Oncology|February 3, 2020
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL ConsortiumCorneel Coens, Madeline Pe, Amylou C Dueck, et al.
Eclinicalmedicine|January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocolsMoreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Nature Medicine|July 25, 2022
Symptoms and risk factors for long COVID in non-hospitalized adultsAnuradhaa Subramanian, Krishnarajah Nirantharakumar, Sarah Hughes, et al.
Eclinicalmedicine|January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trialsJan Rekowski, Christina Guo, Olga Solovyeva, et al.
Clinical Trials (London, England)|August 25, 2018
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trialsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
The Lancet. Oncology|November 8, 2016
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standardsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
BMJ Open|April 27, 2022
Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)Shamil Haroon, Krishnarajah Nirantharakumar, Sarah E Hughes, et al.
BMJ Open|July 1, 2021
SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trialsMelanie Calvert, Madeleine King, Rebecca Mercieca-Bebber, et al.
Pageof 23

Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
BMJ (Clinical Research Ed.)|October 20, 2023
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidanceChristina Yap, Jan Rekowski, Moreno Ursino, et al.
Trials|August 31, 2017
A mixed-methods feasibility and external pilot study to inform a large pragmatic randomised controlled trial of the effects of surgical wound dressing strategies on surgical site infections (Bluebelle Phase B): study protocol for a randomised controlled trial, Barnaby C Reeves, Lazaros Andronis, et al.
The Lancet. Oncology|February 3, 2020
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL ConsortiumCorneel Coens, Madeline Pe, Amylou C Dueck, et al.
Eclinicalmedicine|January 29, 2025
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocolsMoreno Ursino, Guillermo Villacampa, Jan Rekowski, et al.
Nature Medicine|July 25, 2022
Symptoms and risk factors for long COVID in non-hospitalized adultsAnuradhaa Subramanian, Krishnarajah Nirantharakumar, Sarah Hughes, et al.
Eclinicalmedicine|January 29, 2025
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trialsJan Rekowski, Christina Guo, Olga Solovyeva, et al.
Clinical Trials (London, England)|August 25, 2018
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trialsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
The Lancet. Oncology|November 8, 2016
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standardsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
BMJ Open|April 27, 2022
Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)Shamil Haroon, Krishnarajah Nirantharakumar, Sarah E Hughes, et al.
BMJ Open|July 1, 2021
SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trialsMelanie Calvert, Madeleine King, Rebecca Mercieca-Bebber, et al.
Pageof 23